Vol 7, Supplement 4 (April 26, 2018): Translational Cancer Research

Editorial

Neurological complications of anti-PD-1 antibodies: shall we be more concerned?

Kyrillus S. Shohdy, Omar Abdel-Rahman

PDF Pages: S436-S438 Full Text (1675) COI Form Open Access

ZATT, TDP2, and SUMO2: breaking the tie that binds TOP2 to DNA

Steven R. Hall, Kerry Brennan Goralski

PDF Pages: S439-S444 Full Text (2369) COI Form Open Access

Evolutionary acquired robustness and vulnerability in cancer genome: negligible negative selection in carcinogenesis

Kazuki Kumada, Jun Yasuda

PDF Pages: S445-S448 Full Text (2897) COI Form Open Access

Fibroblast growth factor signaling as a bypass mechanism of the androgen receptor pathway: new perspectives for castrationresistant prostate cancer

Ihsan Y. El-Sayed, Francis Vacherot, Stéphane Terry

PDF Pages: S449-S452 Full Text (1732) COI Form Open Access

PD-1 in cancer: Dr. Jekyll and Mr. Hyde

Marion Alcantara, Melania Tesio, Vahid Asnafi

PDF Pages: S453-S456 Full Text (2369) COI Form Open Access

Myc and Ras, the Bonnie and Clyde of immune evasion

Sílvia Casacuberta-Serra, Laura Soucek

PDF Pages: S457-S459 Full Text (3289) COI Form Open Access

Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic

Naomi Lomeli, Daniela A. Bota

PDF Pages: S460-S462 Full Text (4482) COI Form Open Access

The emerging landscape of lncRNAs in diabetic nephropathy

Xiaoyun He, Chibin Pu, Chunlin Ou, Suxian Zhou

PDF Pages: S463-S465 Full Text (1792) COI Form Open Access

A human mutated gene is guillotining spermatozoa

Jesús del Mazo, Miguel A. Brieño-Enríquez, Eduardo Larriba

PDF Pages: S466-S468 Full Text (1560) COI Form Open Access

Hypofractionated whole breast irradiation is cost-effective—but is that enough to change practice?

Apar Gupta, Nisha Ohri, Bruce G. Haffty

PDF Pages: S469-S472 Full Text (5197) COI Form Open Access

Adjuvant chemotherapy in patients with newly diagnosed non-co-deleted anaplastic gliomas—a new standard

Kelly Lauren Braun, David Marc Peereboom

PDF Pages: S473-S475 Full Text (1554) COI Form Open Access

Editorial: fate mapping of human glioblastoma reveals an invariant stem cell hierarchy

Sabrina P. Koh, Agadha C. Wickremesekera, Tinte Itinteang, Swee T. Tan

PDF Pages: S476-S479 Full Text (2025) COI Form Open Access

Duloxetine for AI-associated joint pain in breast cancer patients

Moe Tsuda, Masakazu Toi

PDF Pages: S480-S483 Full Text (2301) Open Access

Temozolomide—the jack of all gliomas? Reviewing the interim results of the CATNON trial for 1p/19q non-co-deleted anaplastic glioma

Mateo Ziu, Jeffrey I. Traylor

PDF Pages: S484-S487 Full Text (2162) COI Form Open Access

When the inhibitor is turned into stimulator: novel aspects in T cell engineering

Felicitas Rataj, Stefan Endres, Sebastian Kobold

PDF Pages: S488-S490 Full Text (1123) Open Access

There must be another way—disulfiram and cancer treatment: editorial on “Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4”

Hovav Nechushtan, Tamar Peretz

PDF Pages: S491-S494 Full Text (7245) COI Form Open Access

Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4

Nan Ding, Qianzheng Zhu

PDF Pages: S495-S499 Full Text (4769) COI Form Open Access

How many pancreatic cysts are out there and how to best manage them?

Victor Ciofoaia, Nadim G. Haddad, Jill P. Smith

PDF Pages: S500-S505 Full Text (5024) COI Form Open Access

The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma

Deborah Cosentini, Sandra Sigala, Elisa Saba, Elisa Roca, Alfredo Berruti

PDF Pages: S506-S509 Full Text (1432) COI Form Open Access

Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma

David C. Binder, Erik Ladomersky, Alicia Lenzen, Lijie Zhai, Kristen L. Lauing, Sebastian D. Otto-Meyer, Rimas V. Lukas, Derek A. Wainwright

PDF Pages: S510-S513 Full Text (4578) COI Form Open Access

Abundant options to avoid toxicity and alternative strategies for human epidermal growth factor receptor 2-positive and hormone receptor-positive advanced breast cancer

Kazuhiro Araki, Yasuo Miyoshi

PDF Pages: S514-S518 Full Text (1927) COI Form Open Access

Role of enhancer activation in pancreatic cancer metastasis

Paloma Cejas, Marta Mendiola, Jaime Feliu

PDF Pages: S519-S520 Full Text (1488) COI Form Open Access

Circular RNA FBXW7: implication in glioma tumorigenesis

Luka Bolha, Damjan Glavač

PDF Pages: S521-S524 Full Text (1758) COI Form Open Access

Improving hormonal therapy: to extend, to intermit, or to readjust expectations?

Iris Noordhoek, Esther Bastiaannet, Cornelis J. H. van de Velde

PDF Pages: S525-S527 Full Text (2563) COI Form Open Access

Letter to the Editor

Is there still room for anti-angiogenic agents in small cell lung cancer?

Matteo Brighenti, Marcello Tiseo

PDF Pages: S528-S529 Full Text (1197) COI Form Open Access

Perspective

PD-1/PD-L1 pathway inhibition to restore effector functions in exhausted CD8⁺ T cells: chances, limitations and potential risks

Priya Veluswamy, Dunja Bruder

PDF Pages: S530-S537 Full Text (6544) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.